aDepartment of Medicine, Baylor College of Medicine, Houston, Texas
bDepartment of Dermatology, University of North Carolina
cDepartment of Epidemiology
dLineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
eDepartment of Applied Mathematics and Statistics, State University of New York, Stony Brook
fDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York
gDepartment of Pathology, New York University School of Medicine, New York
hDepartment of Internal Medicine, University of New Mexico, Albuquerque, New Maxico
iRoswell Park Comprehensive Cancer Center, Elm and Carlton, Buffalo
jDepartment of Applied Mathematics and Statistics, State University of New York, Stony Brook and
kDepartment of Surgery, University of North Carolina, Chapel Hill, North Carolina, USA
Received 1 November 2022 Accepted 23 December 2022.
Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website, www.melanomaresearch.com.
Correspondence to Ivan Gorlov, PhD, Department of Medicine, Baylor College of Medicine, Institute for Clinical & Translational Research’ One Baylor Plaza, Mailstop: BCM451, Houston, TX 77030, USA, Tel: +1 713 798 8595; e-mail: [email protected]